GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
GIP (glucose-dependent insulinotropic polypeptide) is a gastrointestinal hormone that regulates pancreatic islet function. Additionally, emerging evidence suggests an important physiological role for GIP in the regulation of adipocyte metabolism. In previous studies on the lipogenic effects of GIP, it was shown to increase adipocyte lipoprotein lipase (LPL) activity in both differentiated 3T3-L1 cells and human adipocytes through a pathway involving activation of protein kinase B (PKB)/Akt. In the current study, we examined the effects of GIP on LPL gene expression. GIP in the presence of insulin increased LPL gene expression in human adipocytes and LPL promoter activity in GIP receptor-expressing HEK-293 cells, and both effects were greatly reduced by the transcription inhibitor actinomycin D. Subsequent studies established that GIP increased phosphorylation of Serine 133 in cAMP-response element binding protein (CREB) and the nuclear localization of cAMP-responsive CREB coactivator 2 (TORC2) through a pathway involving phosphatidylinositol 3-kinase (PI3-K), PKB, and AMP-activated protein kinase (AMPK). However, in the presence of insulin, GIP failed to activate the cAMP/PKA pathway. Knockdown of CREB and TORC2 using RNA interference reduced LPL expression, supporting a functional regulatory role. GIP-induced phospho-CREB and TORC2 were shown to bind to a cAMP-response element (-II) site in the human LPL promoter and GIP increased protein-protein interactions of these two factors. The lipogenic effects of GIP in the presence of insulin are therefore at least partially mediated by upregulation of adipocyte LPL gene transcription through a pathway involving PI3-K/PKB/AMPK-dependent CREB/TORC2 activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GIP promotes lipogenesis and lipid deposition under conditions of hyperinsulinema [34–36] while stimulating lipolysis and fatty acid oxidation under conditions of normo- or hypoinsulinemia [37–39].”
From Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes (2024) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schreiber, E., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133
Gonzalez, G. A., & Montminy, M. R. (1989) · Cell · doi:10.1016/0092-8674(89)90013-5 · Cited by 2,464
Obesity and the regulation of energy balance
Spiegelman, B. M., & Flier, J. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00240-9 · Cited by 2,398
DeFronzo, R. A., Ratner, R. E., Han, J., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1092 · Cited by 1,559
CREB Is a Regulatory Target for the Protein Kinase Akt/PKB
Du, K., & Montminy, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32377 · Cited by 952
Lipoprotein lipase: from gene to obesity
Wang, H., & Eckel, R. H. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90920.2008 · Cited by 741
The role of gut hormones in glucose homeostasis
Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30076 · Cited by 614
Conkright, M. D., Canettieri, G., Screaton, R., Guzman, E., Miraglia, L., Hogenesch, J. B., & Montminy, M. (2003) · Molecular Cell · doi:10.1016/j.molcel.2003.08.013 · Cited by 602
Savage, D. B., Sewter, C. P., Klenk, E. S., Segal, D. G., Vidal-Puig, A., Considine, R. V., & O’Rahilly, S. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2199 · Cited by 572
Brubaker, P. L., & Drucker, D. J. (2004) · Endocrinology · doi:10.1210/en.2004-0015 · Cited by 540
Merkel, M., Eckel, R. H., & Goldberg, I. J. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200015-jlr200 · Cited by 522
Classification of Human B-ZIP Proteins Based on Dimerization Properties
Vinson, C., Myakishev, M., Acharya, A., Mir, A. A., Moll, J. R., & Bonovich, M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6321-6335.2002 · Cited by 454
Yusta, B., Baggio, L. L., Estall, J. L., Koehler, J. A., Holland, D. P., Li, H., Pipeleers, D., Ling, Z., & Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.10.001 · Cited by 446
Adipogenesis: forces that tip the scales
MacDougald, O. A., & Mandrup, S. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00517-3 · Cited by 355
Resistin Gene Expression in Human Adipocytes Is Not Related to Insulin Resistance
Janke, J., Engeli, S., Gorzelniak, K., Luft, F. C., & Sharma, A. M. (2002) · Obesity Research · doi:10.1038/oby.2002.1 · Cited by 319
Comparison of Vildagliptin and Rosiglitazone Monotherapy in Patients With Type 2 Diabetes
Rosenstock, J., Baron, M. A., Dejager, S., Mills, D., & Schweizer, A. (2007) · Diabetes Care · doi:10.2337/dc06-1815 · Cited by 270
GIF biology and fat metabolism
Yip, R. G. C., & Wolfe, M. M. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00314-8 · Cited by 266
Gastric Inhibitory Polypeptide: Its Physiologic Release and Insulinotropic Action in the Dog
Pederson, R. A., Schubert, H. E., & Brown, J. C. (1975) · Diabetes · doi:10.2337/diab.24.12.1050 · Cited by 253
Kim, S.-J., Winter, K., Nian, C., Tsuneoka, M., Koda, Y., & McIntosh, C. H. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500540200 · Cited by 241
Self-citationFunctional GIP Receptors Are Present on Adipocytes
Yip, R. G.-C., Boylan, M. O., Kieffer, T. J., & Wolfe, M. M. (1998) · Endocrinology · doi:10.1210/endo.139.9.6288 · Cited by 237
Harder, H., Nielsen, L., Thi, T. D. T., & Astrup, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1915 · Cited by 232
Organization of the human lipoprotein lipase gene and evolution of the lipase gene family.
Kirchgessner, T. G., Chuat, J. C., Heinzmann, C., Etienne, J., Guilhot, S., Svenson, K., Ameis, D., Pilon, C., d'Auriol, L., & Andalibi, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9647 · Cited by 229
Adipocyte metabolism and obesity
Attie, A. D., & Scherer, P. E. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800057-jlr200 · Cited by 225
Gastric Inhibitory Polypeptide Enhanced Lipoprotein Lipase Activity in Cultured Preadipocytes
Eckel, R. H., Fujimoto, W. Y., & Brunzell, J. D. (1979) · Diabetes · doi:10.2337/diab.28.12.1141 · Cited by 219
Activation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in Adipocytes
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609088200 · Cited by 216
Self-citationOben, J., Morgan, L., Fletcher, J., & Marks, V. (1991) · Journal of Endocrinology · doi:10.1677/joe.0.1300267 · Cited by 188
Chapter 15 Glucose‐Dependent Insulinotropic Polypeptide (Gastric Inhibitory Polypeptide; GIP)
McIntosh, C. H. S., Widenmaier, S., & Kim, S. (2009) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)00615-8 · Cited by 171
Self-citationGastric Inhibitory Polypeptide
Brown, J. C. (1982) · Monographs on endocrinology · doi:10.1007/978-3-642-81771-7 · Cited by 171
Ehses, J. A., Casilla, V. R., Doty, T., Pospisilik, J. A., Winter, K. D., Demuth, H.-U., Pederson, R. A., & McIntosh, C. H. S. (2003) · Endocrinology · doi:10.1210/en.2002-0068 · Cited by 159
Self-citationKim, S., Nian, C., Widenmaier, S. B., & McIntosh, C. H. S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00325-07 · Cited by 159
Self-citationEffect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs.
Wasada, T., McCorkle, K., Harris, V, Kawai, K., Howard, B., & Unger, R. H. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110335 · Cited by 153
McTernan, P. G., Kusminski, C. M., & Kumar, S. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000217899.59820.9a · Cited by 148
Individual CREB‐target genes dictate usage of distinct cAMP‐responsive coactivation mechanisms
Xu, W., Kasper, L. H., Lerach, S., Jeevan, T., & Brindle, P. K. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601734 · Cited by 140
Song, D. H., Getty–Kaushik, L., Tseng, E., Simon, J., Corkey, B. E., & Wolfe, M. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.005 · Cited by 137
Knapper, J. M. E., Puddicombe, S. M., Morgan, L., & Fletcher, J. M. (1995) · Journal of Nutrition · doi:10.1093/jn/125.2.183 · Cited by 126
Davidson, M. B., Bate, G., & Kirkpatrick, P. N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1828 · Cited by 125
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704896200 · Cited by 118
Self-citationWidenmaier, S. B., Ao, Z., Kim, S., Warnock, G. L., & McIntosh, C. H. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060178 · Cited by 111
Self-citationDu, K., Asahara, H., Jhala, U. S., Wagner, B. L., & Montminy, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.12.4320-4327.2000 · Cited by 106
Immunoreactive Gastric Inhibitory Polypeptide*
Krarup, T. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-1-122 · Cited by 103
Ebert, R., Nauck, M., & Creutzfeldt, W. (1991) · Hormone and Metabolic Research · doi:10.1055/s-2007-1003745 · Cited by 79
McIntosh, C. H. S., Bremsak, I., Lynn, F. C., Gill, R., Hinke, S. A., Gelling, R., Nian, C., McKnight, G., Jaspers, S., & Pederson, R. A. (1999) · Endocrinology · doi:10.1210/endo.140.1.6464 · Cited by 73
Self-citationDipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for Type 2 diabetes
Deacon, C. F. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.4.533 · Cited by 66
Dipeptidyl peptidase iv inhibitors and diabetes therapy
McIntosh, C. H. S. (2007) · Frontiers in bioscience · doi:10.2741/2797 · Cited by 62
Self-citationKim, S.-J., Choi, W. S., Han, J. S. M., Warnock, G., Fedida, D., & McIntosh, C. H. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504913200 · Cited by 42
Self-citationDifferential activation of CREB by Akt1 and Akt2
Kato, S., Ding, J., & Du, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.094 · Cited by 31
Task Force on Developing Obesity Outcomes and Learning Standards (TOOLS)
Wolf, A. (2002) · Obesity Research · doi:10.1038/oby.2002.180 · Cited by 29
Bey, L., Etienne, J., Tsé, C., Brault, D., Noé, L., Raisonnier, A., Arnault, F., Hamilton, M. T., & Galibert, F. (1998) · Gene · doi:10.1016/s0378-1119(98)00003-1 · Cited by 26
Beck, B., & Max, J. (1986) · Diabetologia · doi:10.1007/bf02427284 · Cited by 26
Jorde, R., Pettersen, J. E., & BURHOL, P. G. (1984) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1984.tb03765.x · Cited by 19
Expression and Regulation of the Lipoprotein Lipase Gene in Human Adrenal Cortex
Staels, B., Martin, G., Martínez, M., Albert, C., Peinado‐Onsurbe, J., Saladin, R., Hum, D. W., Reina, M., Vilaró, S., & Auwerx, J. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17425 · Cited by 18
Peinado‐Onsurbe, J., Staels, B., Deeb, S. S., et al. (1992) · Biochemistry · doi:10.1021/bi00156a036 · Cited by 16
Effect of endogenous gastric inhibitory polypeptide (GIP) on the removal of triacylglycerol in dogs
Ohneda, A., Kobayashi, T., & Nihei, J. (1983) · Regulatory Peptides · doi:10.1016/0167-0115(83)90131-3 · Cited by 16
Metabolic Effects of Gastric Inhibitory Polypeptide
Ebert, R., & Creutzfeldt, W. (2015) · Frontiers of hormone research · doi:10.1159/000414308 · Cited by 11
Cited by
Incretin hormones: Their role in health and disease
Nauck, M. A., & Meier, J. J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13129 · Cited by 950
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007218 · Cited by 696
The multiple functions and mechanisms of osteopontin
Icer, M. A., & Gezmen-Karadag, M. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.07.003 · Cited by 606
Physiological regulation of lipoprotein lipase
Kersten, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.03.013 · Cited by 550
Cardiovascular Biology of the Incretin System
Ussher, J. R., & Drucker, D. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1052 · Cited by 530
Metadata
- Authors
- Kim, S.-J., Nian, C., & McIntosh, C. H. S.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- McIntosh, Christopher H.S.
- ORCID
- Kim, Su-Jin
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 51
- Issue
- 11
- Pages
- 3145-3157
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC2952555
- OpenAlex
- W1995969505
- Cited by
- 133
- References
- 55
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 19 · 2023: 10 · 2022: 8 · 2021: 8 · 2020: 7 · 2019: 9 · 2018: 6 · 2017: 6 · 2016: 2 · 2015: 6 · 2014: 7 · 2013: 4 · 2012: 9
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 3638 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Diabetes Association
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- glucose-dependent insulinotropic polypeptide, lipoprotein lipase, CREB phosphorylation, TORC2, insulin, cAMP response element, GIP receptor
- MeSH terms
- Adult, Cell Nucleus, Female, Gastric Inhibitory Polypeptide, Humans, Lipoprotein Lipase, Middle Aged, Phosphoproteins, Phosphorylation, Promoter Regions, Genetic, Transcription Factors, Transcription, Genetic, Transcriptional Activation, Gene Expression Regulation, Enzymologic, Cyclic AMP Response Element-Binding Protein, Adipocytes, Phosphatidylinositol 3-Kinases, Active Transport, Cell Nucleus, Proto-Oncogene Proteins c-akt, AMP-Activated Protein Kinases, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.